Clinical trial Recruiting at 19 sites Observational Ages 18 and up

Research on improving outcomes for lung transplant donors and recipients

Official title: Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes: PROMISE-Lung Study

Run by Duke University · NCT06399302 · Data updated 2026-11-12

This study is trying to see how different donor and medical practices affect the health of lung transplant patients and donors, while also looking for blood markers that might predict complications after the surgery.

More Lung Transplant trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment2600 (estimated)
SponsorDuke University
Academic / other
Locations19 sites (Los Angeles, California and 18 other locations)
StatusRecruiting
StartedSeptember 3, 2024
Main results expectedJune 30, 2027
Study endsJune 30, 2027
Registry record updatedAugust 7, 2026
Trial IDNCT06399302 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older who are listed for or have recently undergone a lung transplant.

Probably not a fit

Patients who are unwilling to provide informed consent or have significant medical issues that may complicate participation may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to gather extensive clinical data, blood samples, and patient-reported outcomes from 2,600 lung transplant candidates, donors, and recipients across multiple centers. The research will focus on understanding how variations in donor and medical practices affect clinical outcomes and will identify serum biomarkers that predict post-transplant complications. Participants will be recruited either before their lung transplant or within 30 days after the procedure, with data collected during standard care visits to minimize additional burdens on participants. The study is designed to create a valuable resource for future research in lung transplantation.

Why it matters

Potential benefit: If successful, this study could lead to improved management strategies and better outcomes for lung transplant patients.

How similar studies have gone: Other studies have shown success in using similar observational approaches to improve transplant outcomes, indicating that this methodology is both tested and promising.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Able to understand and provide informed consent
2. ≥ 18 years of age at the time of written informed consent
3. Anticipated listing or listed for a single or bilateral cadaveric donor lung transplant or having received a lung transplant within 30 days

   * Participants undergoing repeat lung transplantation or multi-organ transplantation are eligible if they meet the inclusion/exclusion criteria.

Exclusion Criteria:

1. Unwillingness of a participant or legally authorized representative (LAR) to give written informed consent or comply with study protocol
2. Pregnancy or plans to become pregnant
3. Past or current medical problems or findings from physical examination or laboratory testing, which, in the opinion of the investigator, may pose additional risks from participation in the study, may interfere with the participant's ability to comply with study requirements or that may impact the quality or interpretation of the data obtained from the study.

Where it's running

  • University of California Los Angeles
    Los Angeles, California, United States
    Recruiting
  • University of California at San Francisco
    San Francisco, California, United States
    Recruiting
  • Stanford University Medical Center
    Stanford, California, United States
    Recruiting
  • University of Miami
    Miami, Florida, United States
    Recruiting
  • Johns Hopkins University
    Baltimore, Maryland, United States
    Recruiting
  • Brigham and Womens Hospital
    Boston, Massachusetts, United States
    Recruiting
Show 13 more locations
  • University of Michigan
    Ann Arbor, Michigan, United States
    Recruiting
  • University of Minnesota
    Minneapolis, Minnesota, United States
    Recruiting
  • New York University
    New York, New York, United States
    Recruiting
  • Columbia University
    New York, New York, United States
    Recruiting
  • Duke University Medical Center
    Durham, North Carolina, United States
    Recruiting
  • University of Pennsylvania
    Philadelphia, Pennsylvania, United States
    Recruiting
  • University of Pittsburgh Medical Center
    Pittsburgh, Pennsylvania, United States
    Recruiting
  • Vanderbilt University Medical Center
    Nashville, Tennessee, United States
    Recruiting
  • Houston Methodist Hospital, Texas Medical Center
    Houston, Texas, United States
    Recruiting
  • Inova Fairfax Hospital
    Falls Church, Virginia, United States
    Recruiting
  • University of Washington
    Seattle, Washington, United States
    Recruiting
  • University of Wisconsin Hospital and Clinics
    Madison, Wisconsin, United States
    Recruiting
  • University Health Network
    Toronto, Canada, Canada
    Recruiting

Study contacts

  • Principal investigator: Scott M Palmer, MD, MHS — Duke University School of Medicine, Department of Medicine
  • Study coordinator: Allyn Damman
  • Email: allyn.damman@duke.edu
  • Phone: 919-259-4414

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.